Form D — NurExone Biologic Inc.

0001062993-25-001002 · filed Jan 22, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $434,512
Reported amount sold: $434,512
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: NurExone Biologic Inc.
CIK: 1995074
Entity: Corporation
Jurisdiction: ONTARIO, CANADA
Year incorporated: 2025
Address: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B
TECHNION CITY, HAIFA, L3 3200003
Phone: 972 52-4803034

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Lior Shaltiel · Executive Officer

Technion City, Haifa, L3 Find on LinkedIn ↗
Eran Ovadya · Executive Officer

Technion City, Haifa, L3 Find on LinkedIn ↗
Yoram Drucker · Executive Officer

Technion City, Haifa, L3 Find on LinkedIn ↗
Oded Orgil · Director

Calgary, A0 Find on LinkedIn ↗
James Richardson · Director

Calgary, A0 Find on LinkedIn ↗

Other filings from this issuer

View the original filing on SEC EDGAR ↗